Abstract YO7
Case summary
Introduction:
The orbit is an unusual site for metastatic cancer. Orbital metastasis is believed to occur in approximately 2% to 3% of patients with systemic cancer.
Case Presentation:
A 58-year-old male with history of three month history of on and off orbital swelling presented with right hip pain. He had a history of high-risk prostate cancer July 2019 status post radical prostatectomy, leuprolide and salvage radiotherapy. He was put on androgen deprivation therapy(ADT) break from December 2021 until repeat PSA in April 2022 was 107. A repeat CT-CAP and bone scan on 4/21/2022 which showed diffuse bony metastasis including R iliac wing and calvarium. Patient was started on degarelix and sent to a medical oncologist. He was started on leuprolide and enzalutamide and received palliative radiotherapy for right hip pain. During his radiotherapy patient developed worsening right hip pain for which he had to be admitted.On day 3 of admission patient developed significant chemosis, significant extraocular muscle restriction particularly in abduction. CT Scan of the maxillofacial region showed significant right periorbital swelling with potential post septal involvement noted on the right. Multiple calvarial lesions were also noted. Magnetic resonance imaging (MRI) head showed tumor infiltration of the skull base and frontal bones with intraorbital extraconal subperiosteal tumor and bifrontal epidural tumor extension. Steroids were started. Periorbital swelling resolved on day 6. Biopsy was deferred.
Discussion
The median age for orbital metastasis reported is at 70 years however our patient is younger. In general, patients present with ocular symptoms such as decreased vision, diplopia, proptosis and periorbital edema. Metastatic cancer most commonly develops in the uveal tract. Metastasis to the retina, optic disc, and vitreous are relatively uncommon. Metastasis to the bony orbit although rare, has been reported in the past. Extraconal space is the area outside musculofascial cone in the eye. Although both bony and soft tissue metastasis involving the uveal tract have been reported in the past, extraconal orbital soft tissue metastasis secondary to PC is only reported once and is extremely rare.Treatment options include ADT and cranial irradiation.
Clinical trial identification
Editorial acknowledgement
Resources from the same session
461P - Spectrum of immune related adverse events (irAE) on treatment with checkpoint inhibitors and its association with survival: A real-world experience from India
Presenter: Nitin Murthy
Session: Poster viewing 06
462P - Limited duration of treatment with checkpoint inhibitors in complete responders, yet prolonged survival: A real-world study from India
Presenter: Nitin Murthy
Session: Poster viewing 06
463P - Cost effectiveness of palbociclib and ribociclib in metastatic breast cancer in India using ICER and QALY
Presenter: Krishnamani Kalpathi
Session: Poster viewing 06
464TiP - Phase III study of adjuvant encorafenib plus binimetinib vs placebo in fully resected stage IIB/C BRAFV600-mutated melanoma: COLUMBUS-AD study design
Presenter: Alexander van Akkooi
Session: Poster viewing 06
465TiP - Evaluation of quality of life and functional outcomes following limb salvage surgery in extremities sarcomas
Presenter: naveen kushwaha
Session: Poster viewing 06
YO2 - A case of locally advanced breast cancer with biomarker conversion successfully treated with neoadjuvant chemotherapy-immunotherapy combination
Presenter: Long Nguyen
Session: Poster viewing 06
YO3 - Metastatic Breast cancer to esophagus: A case report and review of literature
Presenter: Bhuvana J
Session: Poster viewing 06
YO4 - Succinate Dehydrogenase deficient GISTs is a diagnostic and therapeutic dilemma? : A case report.
Presenter: Nurazzahra Kamarudin
Session: Poster viewing 06
YO5 - Complete Radiologic and Pathologic Response in a Metastatic Gallbladder Adenocarcinoma Patient treated with Checkpoint Inhibitor/Chemotherapy Combination: A Case Report
Presenter: Tisha Gay Tancongco
Session: Poster viewing 06
YO10 - BRCA2 Mutated Recurrent Adult Granulosa Cell Tumor Treated with PARP Inhibitor
Presenter: Debapriya Mondal
Session: Poster viewing 06